• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙烯醇对基于无表面活性剂的HFA 134a的压力定量吸入器中喷雾干燥蛋白质颗粒的体外稳定性和递送的影响。

The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.

作者信息

Liao Yong-Hong, Brown Marc B, Jones Stuart A, Nazir Tahir, Martin Gary P

机构信息

Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Xi Bei Wang, Hai Dian District, Beijing 100094, PR China.

出版信息

Int J Pharm. 2005 Nov 4;304(1-2):29-39. doi: 10.1016/j.ijpharm.2005.07.013. Epub 2005 Sep 21.

DOI:10.1016/j.ijpharm.2005.07.013
PMID:16181753
Abstract

The objective of the present study was to investigate the physical stability of spray-dried proteins within surfactant-free hydrofluoroalkane (HFA) pressurised metered dose inhalers (pMDIs) during prolonged storage. Two model proteins (lysozyme and catalase) were spray-dried and stabilised in the presence of excipients, and subsequently suspended within HFA 134a. The pMDIs were stored valve-up for 6 months at room temperature (ca. 25 degrees C). Activities of the proteins were determined using biological assays and the fine particle fraction of the pMDIs was measured using a twin-stage impinger. The biological activities of catalase and lysozyme were found to be preserved in the presence of sugars and/or 80% hydrolysed polyvinyl alcohol (PVA) during spray drying. In addition, suspending the stabilised proteins within HFA for up to 6 months had little effect on their activity. The aerosolisation performance of lysozyme or catalase formulations containing either sucrose or trehalose as stabilisers appeared to deteriorate as a function of storage time. However, those formulations containing PVA were found to generate the greatest fine particle fraction, which in some cases was up to 50%, and to possess excellent physical stability during storage. The results indicated that the presence of PVA in the spray-dried stabilised protein particles could enhance the physical stability of particles, when suspended in the surfactant-free HFA MDI formulations, without affecting the protein stability upon prolonged storage.

摘要

本研究的目的是调查无表面活性剂的氢氟烷烃(HFA)压力定量吸入器(pMDI)中喷雾干燥蛋白质在长期储存期间的物理稳定性。将两种模型蛋白(溶菌酶和过氧化氢酶)进行喷雾干燥,并在辅料存在的情况下进行稳定化处理,随后悬浮于HFA 134a中。将pMDI阀门向上在室温(约25摄氏度)下储存6个月。使用生物学测定法测定蛋白质的活性,并使用双级冲击器测量pMDI的细颗粒部分。发现在喷雾干燥过程中,在糖和/或80%水解聚乙烯醇(PVA)存在的情况下,过氧化氢酶和溶菌酶的生物学活性得以保留。此外,将稳定化的蛋白质在HFA中悬浮长达6个月对其活性影响很小。含有蔗糖或海藻糖作为稳定剂的溶菌酶或过氧化氢酶制剂的雾化性能似乎会随着储存时间的延长而变差。然而,发现那些含有PVA的制剂产生的细颗粒部分最大,在某些情况下高达50%,并且在储存期间具有优异的物理稳定性。结果表明,喷雾干燥的稳定化蛋白质颗粒中PVA的存在可以增强颗粒的物理稳定性,当悬浮于无表面活性剂的HFA MDI制剂中时,在长期储存时不会影响蛋白质的稳定性。

相似文献

1
The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.聚乙烯醇对基于无表面活性剂的HFA 134a的压力定量吸入器中喷雾干燥蛋白质颗粒的体外稳定性和递送的影响。
Int J Pharm. 2005 Nov 4;304(1-2):29-39. doi: 10.1016/j.ijpharm.2005.07.013. Epub 2005 Sep 21.
2
Novel pMDI formulations for pulmonary delivery of proteins.新型 PMDI 制剂用于肺部蛋白递药。
Int J Pharm. 2010 Jan 29;385(1-2):73-8. doi: 10.1016/j.ijpharm.2009.10.032. Epub 2009 Oct 23.
3
Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.由喷雾干燥的布地奈德微晶分散在HFA-134a中组成的混悬型定量吸入气雾剂制剂的特性研究
Pharm Res. 2004 Sep;21(9):1607-14. doi: 10.1023/b:pham.0000041455.13980.f1.
4
Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.新型推进剂驱动的吸入制剂:利用表面捕获的氢氟烷烃亲和物设计极性药物颗粒。
Eur J Pharm Sci. 2008 Feb 5;33(2):146-58. doi: 10.1016/j.ejps.2007.10.007. Epub 2007 Nov 9.
5
Investigation of the physical properties of spray-dried stabilised lysozyme particles.喷雾干燥稳定化溶菌酶颗粒的物理性质研究
J Pharm Pharmacol. 2003 Sep;55(9):1213-21. doi: 10.1211/0022357021611.
6
Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules.使用生物相容性大分子对倍氯米松 - 氢氟烷相互作用进行调控。
J Pharm Sci. 2006 May;95(5):1060-74. doi: 10.1002/jps.20608.
7
Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.环孢素定量吸入器(MDI)制剂的评估。
J Pharm Pharmacol. 2007 Jan;59(1):15-21. doi: 10.1211/jpp.59.1.0003.
8
The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants.含蛋白质纳米颗粒在氢氟烷烃推进剂中的悬浮处理。
Int J Pharm. 2009 May 8;372(1-2):140-6. doi: 10.1016/j.ijpharm.2009.01.005. Epub 2009 Jan 17.
9
Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.储存方向对含有推进剂HFA - 227的混悬型定量吸入器空气动力学粒径的影响。
Drug Dev Ind Pharm. 2003 Jul;29(6):631-9. doi: 10.1081/ddc-120021312.
10
Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.采用自下而上工艺制备的胸腺五肽纳米粒经压定量吸入器的稳定性和空气动力学特性。
Int J Pharm. 2012 May 10;427(2):385-92. doi: 10.1016/j.ijpharm.2012.02.002. Epub 2012 Feb 11.

引用本文的文献

1
Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy.用于预防和治疗 SARS-CoV-2 的被动免疫疗法的呼吸道输送。
Hum Vaccin Immunother. 2023 Aug;19(2):2260040. doi: 10.1080/21645515.2023.2260040. Epub 2023 Oct 6.
2
Effect of MDI Actuation Timing on Inhalation Dosimetry in a Human Respiratory Tract Model.定量吸入气雾剂启动时间对人体呼吸道模型吸入剂量测定的影响
Pharmaceuticals (Basel). 2022 Jan 4;15(1):61. doi: 10.3390/ph15010061.
3
Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation.
分析影响无纺纤维基质作为腺病毒载体疫苗稳定剂性能的因素。
Sci Rep. 2021 Oct 22;11(1):20877. doi: 10.1038/s41598-021-00065-4.
4
Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections.吸入型单克隆抗体治疗:一种治疗和管理呼吸道感染的新方法。
Appl Microbiol Biotechnol. 2021 Aug;105(16-17):6315-6332. doi: 10.1007/s00253-021-11488-4. Epub 2021 Aug 23.
5
Sesquiterpene-Loaded Co-Polymer Hybrid Nanoparticle Effects on Human Mast Cell Surface Receptor Expression, Granule Contents, and Degranulation.负载倍半萜的共聚物杂化纳米颗粒对人肥大细胞表面受体表达、颗粒内容物及脱颗粒的影响。
Nanomaterials (Basel). 2021 Apr 8;11(4):953. doi: 10.3390/nano11040953.
6
Pulmonary Delivery of Biological Drugs.生物药物的肺部给药
Pharmaceutics. 2020 Oct 26;12(11):1025. doi: 10.3390/pharmaceutics12111025.
7
Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.一种温度稳定型冻干卡介苗疫苗的设计与优化。
Pharm Res. 2019 Dec 23;37(1):11. doi: 10.1007/s11095-019-2739-8.
8
Advances in metered dose inhaler technology: formulation development.定量吸入器技术进展:制剂研发
AAPS PharmSciTech. 2014 Apr;15(2):434-55. doi: 10.1208/s12249-013-0063-x. Epub 2014 Jan 23.
9
Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.疫苗佐剂-控制释放佐剂性的现状和前景。
Saudi Pharm J. 2011 Oct;19(4):197-206. doi: 10.1016/j.jsps.2011.06.003. Epub 2011 Jun 25.
10
Protocols for dry DNA storage and shipment at room temperature.干态 DNA 室温储存及运输方案
Mol Ecol Resour. 2013 Sep;13(5):890-8. doi: 10.1111/1755-0998.12134. Epub 2013 Jun 24.